RCAT vs TECH · rev $9.6M vs P/E 65, rev $1.22B
Red Cat Holdings Inc (RCAT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Red Cat Holdings Inc (RCAT) is a aerospace & defense company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RCAT revenue for 2025-09-30 was $9.6M. Net income was -$16.0M. RCAT currently screens at market cap $1.70B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RCAT currently screens at market cap $1.70B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RCAT and TECH stock pages for the full models.
Not investment advice.